kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the TBPH dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for TBPH.

TBPH

Theravance Biopharma, Inc.
Healthcare · Biotechnology
$284.60 sample
+4.93 (+1.76%) 1D
☆ Watch
Market cap
$1.07T
Price as of
2026-10-29
Latest filing
8-K
Alerts
8
Price$284.60 +12.98% 3M daily closessample
284.60244.01
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 27INSInsider sell: EVP, Operations
  • Oct 20INSInsider buy: General Counsel
  • Oct 13INSInsider sell: Chief Financial Officer
  • Oct 08INSInsider buy: General Counsel
  • Oct 01INSInsider sell: 10% owner
  • Sep 25INSInsider sell: Director
  • Sep 21INSInsider buy: Chief Financial Officer
  • Sep 15INSInsider sell: 10% owner
Sign up to see the real TBPH record →

Company facts

SEC EDGAR registration
Name
Theravance Biopharma, Inc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
+60sample, -100 to +100
Reporting currency
USD

Who is positioning in TBPH

sample
Insiders
12 insider transactions over 90 days, net selling, $642.8M
Congress
3 members traded over 90 days
Institutions · 13F
35 funds hold $21.6B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$74.2B +21.8% y/y
Q4 2024Q3 2026
Inventory$41.0B +11.3% y/y
Q4 2024Q3 2026
Accounts receivable$33.0B +10.2% y/y
Q4 2024Q3 2026
Total debt$88.4B +16.2% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$677.4B -10.6% 3M
Sample peer B
$985.7B +1.1% 3M
Sample peer C
$894.2B +3.9% 3M
Sample peer D
$991.1B +9.9% 3M
Sample peer E
$450.8B -5.4% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not TBPH's real figure. Nothing here is investment advice.